ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

23andMe Research Institute Appoints Privacy Advisory Board

PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, today announced the formation of its Privacy Advisory Board. Composed of leading experts in health data privacy, data ethics, and consumer advocacy, the Board will provide strategic guidance on the protection of member information and the organization’s responsible stewardship of personal data.

"We have always been committed to giving individuals control over their data with choice and transparency," said Anne Wojcicki, Founder and CEO of 23andMe Research Institute. "The establishment of this board, with its deep and diverse expertise, reflects our dedication to ensuring our policies and practices reflect the highest standards of data protection and ethical use while we continue to pioneer genetic discovery."

The Privacy Advisory Board will advise 23andMe Research Institute on critical issues, including:

  • Protection of member information and the responsible stewardship of personal data.
  • Navigating evolving data privacy regulations.
  • Assessing the privacy implications of new technologies and services.

Members of the 23andMe Research Institute Privacy Advisory Board include:

  • Peggy Bodin, Chief Privacy Officer and Chief Privacy Counsel at HCA Healthcare. Bodin holds extensive experience in healthcare privacy and compliance across medical device, pharmaceutical, and biotech industries. Bodin brings practical expertise navigating the European Data Protection Act, General Data Protection Regulation (GDPR), Privacy Shield, Health Insurance Portability and Accountability Act (HIPAA), FTC, Canadian PIPEDA, State Privacy and Breach Notification Laws, Employee Privacy Regulations, Safe Harbor Certification, Compliance, CISO Collaboration, Emergency Medical Treatment And Labor Act (EMTALA), Stark Laws, and the HITECH Act.
  • Fred Cate, Distinguished Professor, C. Ben Dutton Professor of Law, and Adjunct Professor of Informatics and Computing at Indiana University; Executive Director of the Information Accountability Foundation; and co-founder and principal of Red Barn Strategy, a data strategy consulting firm. He has testified before numerous congressional committees and served on and chaired advisory groups for DHS, DOD, NSA, FTC, OECD, the National Academies of Science, Engineering, and Medicine, the UN, and other organizations.
  • Jonathan Zittrain, the George Bemis Professor of International Law at Harvard Law School. He is also a Professor of Public Policy, Harvard John F. Kennedy School of Government, a professor of computer science at the Harvard School of Engineering and Applied Sciences, director of the Harvard Law School Library, and co-founder and director of Harvard’s Berkman Klein Center for Internet & Society. Zittrain is a member of the American Academy of Arts and Sciences and the Board of Directors of the Electronic Frontier Foundation. He has served on the Board of Advisors for Scientific American, as a Trustee of the Internet Society, and as a Forum Fellow of the World Economic Forum, which named him a Young Global Leader. He was the Distinguished Scholar-in-Residence at the Federal Communications Commission, where he chaired the Open Internet Advisory Committee.

The formation of the Privacy Advisory Board reinforces 23andMe Research Institute’s proactive approach to data privacy. It will help ensure the organization continues to innovate responsibly, while safeguarding sensitive personal information, and prioritizing the trust of our members and the research community.

About 23andMe Research Institute

23andMe Research Institute is a nonprofit medical research organization that enables people everywhere to access their genetic information, learn about themselves and participate in the world's largest crowdsourced research initiative. The Institute aims to be the world's most significant contributor to scientific advancement, uniting people with the common goal of improving health and deepening our understanding of DNA — the code of life.

Media Contact:
Catherine Afarian
23andMe Research Institute
408.656.8872
catherine.afarian@23andme.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.